Signalen Lareb

Op deze pagina vindt u een overzicht van berichten aan het College ter Beoordeling van Geneesmiddelen (CBG).

Geef een woord om de resultaten op te filteren:

Titel Bestand
A combination of metoclopramide and selective serotonin reuptake inhibitors: additional extrapyramidal effects? kwb_2005_1_metoc.pdf
Ace-inhibitors and hallucinations kwb_2006_2_acein.pdf
ACE-inhibitors and nightmares or abnormal dreaming kwb_2009_4_acein.pdf
Acetylcysteine and diarrhoea kwb_2002_4_acety.pdf
Adalimumab and pustular psoriasis kwb_2009_3_adali.pdf
Alendronate sodium and uveitis kwb_2002_4_alend.pdf
Alpha-1 blocking agents and liver disorders 2009-1 LQR alpha blocking agents and liver disorders.pdf
Amlodipine en fotosensitiviteit kwb_2007_3_amlod.pdf
Amoxiciline-clavulaanzuur (Augmentin®) en leverfunctiestoornissen kwb_2001_1_amoxi.pdf
An overview of reports concerning implantation complications and unintended pregnancy on etonogestrel kwb_2002_2_impla.pdf
An overview of reports on montelukast kwb_2002_3_monte.pdf
An overview of reports on sirolimus kwb_2002_1_sirol.pdf
An overview of reports on tiotropium bromide kwb_2003_1_tiotr.pdf
Anaphylactic reaction on sulphur hexafluoride kwb_2004_1_sulph.pdf
Anaphylactic reactions on the combination of paracetamol, propyphenazone and caffeine (Saridon®) kwb_2004_2_sarid.pdf
Anaphylactic shock associated with technetium (99mTc)-labelled albumin macroaggregates kwb_2002_2_maaso.pdf
Angioedema and allergic reactions in metoclopramide containing products 2009-1 LQR angioedema and allergic reactions in metoclopramide containing products.pdf
Angiotensine II AT1 receptor antagonists and nightmares or abnormal dreaming kwb_2009_2_angio.pdf
Angiotensin-II receptor antagonists and paraesthesia 2008-4 LQR - Angiotensin-II receptor antagonists and paraesthesia.pdf
Anti-epileptic drugs and suicidal behaviour kwb_2008_2_antiep.pdf
AT1-receptor antagonists and psoriasis kwb_2006_1_angio.pdf
Atomoxetine and tics 2009-1 LQR atomoxetine and tics.pdf
Azathioprine and photosensitivity reactions kwb_2008_1_azath.pdf
Bisphosphonates and alopecia kwb_2008_2_alendr.pdf
Bisphosponates and stomatitis kwb_2009_2_bisph.pdf
Bosentan and coagulation disorders kwb_2005_2_bosen.pdf
Bronchiectasis in children in association with mycophenolate mofetil kwb_2002_3_mycop.pdf
Bupropion and cardiac ischaemia 2009-1 LQR bupropion and cardiac ischaemia.pdf
Bupropion and suicidality kwb_2006_2_bupro.pdf
Cardiac failure and dyspnoea associated with the use of itraconazole kwb_2002_1_itrac.pdf
Cefepime en neuropsychiatric symptoms kwb_2001_4_cefep.pdf
Cetirizine, levocetirizine and arthralgia kwb_2007_2_cetir.pdf
Cisapride and cardiac arrhythmia: what advice should be given on the frequency of ECG-check? kwb_2004_3_cisap.pdf
Cisplatin and cerebral infarction kwb_2008_1_cispla.pdf
Citalopram and priapism kwb_2006_4_citalopr.pdf
Claritromycine en psychotische verschijnselen kwb_2000_4_clari.pdf
Clonidine and weight gain kwb_2007_3_cloni.pdf
Clopidogrel en trombotische trombocytopenische purpura kwb_2000_3_clopi.pdf
Clozapine, olanzapine and rhabdomyolysis kwb_2004_3_cloza.pdf
Concurrent use of verapamil or diltiazem and HMG-CoA reductase inhibitors increases the risk of muscle related ADRs kwb_2003_2_stati.pdf
Cosopt® oogdruppels en sinusitis kwb_2001_3_cosop.pdf
Cyproterone acetate and osteoporosis kwb_2003_1_cypro.pdf
Desmopressin and psychiatric effects kwb_2004_2_desmo.pdf
Domperidone and convulsions kwb_2008_1_domp.pdf
Doxycycline and (photo-)onycholysis kwb_2003_1_doxyc.pdf
Doxycycline and smell and taste disorders kwb_2009_4_doxyc.pdf
Fexofenadine and bradycardia kwb_2009_3_fexof.pdf
Fluconazol en fixed drug eruptions kwb_2007_3_fluc.pdf
Fluconazole and fixed drug eruption kwb_2003_1_fluco.pdf
Fluorescein and anaphylactic reactions kwb_2007_4_fluor.pdf
Fluticasone inhalation and behavioual changes in children kwb_2006_2_fluti.pdf
Gabapentin and various sexual disorders kwb_2002_2_gabap.pdf
GnRH agonists leuprorelin, buserelin or triptorelin and epiphysiolysis kwb_2002_3_GnRHa.pdf
Gosereline and psychiatric disorders in the treatment of prostate cancer kwb_2006_3_goser.pdf
Haloperidol and visual disturbances kwb_2003_4_halop.pdf
HMG coA reductase inhibitors and pulmonary fibrosis kwb_2008_3_statin.pdf
HMG-CoA-reductase inhibitors and decreased libido kwb_2002_4_stati.pdf
HMG-CoA-reductase inhibitors and hypersensitivity pulmonary reactions kwb_2005_2_stati.pdf
HMG-CoA-reductase inhibitors and lichenoid eruption kwb_2004_2_stati2.pdf
HMG-CoA-reductase inhibitors and neuropathy kwb_2004_1_stati.pdf
HMG-CoA-reductase inhibitors and nightmares or abnormal dreaming kwb_2008_3_statins.pdf
HMG-CoA-reductase inhibitors and taste disorders kwb_2004_2_stati.pdf
Hydroquinine hydrobromide and visual disturbances kwb_2003_3_hydro.pdf
Hydroxychloroquine and hearing loss kwb_2005_3_hydro.pdf
Hyperpigmentatie tijdens het gebruik van SSRI’s kwb_2001_3_ssris.pdf
Hypothermia and antipsychotic drugs kwb_2008_2_antips.pdf
Imiquimod and severe skin disorders kwb_2007_2_imiqui.pdf
Increased use of metformin and lactic acidosis kwb_2003_1_metfo.pdf
Infections can increase clozapine levels, resulting in delirium: an update kwb_2004_1_cloza.pdf
Infliximab and listeria monocytogenes meningitis kwb_2003_1_infli.pdf
Infliximab and questionable efficacy of recommendations on tuberculosis screening kwb_2004_3_infli.pdf
Influenza like symptoms after vaginal application of estriol kwb_2008_2_estr.pdf
Inhaled fluticason and haematoma kwb_2007_4_flut.pdf
Itraconazole and erectile dysfunction kwb_2005_4_itra.pdf
Itraconazole and pancreatitis 2008-4 LQR - Itraconazole and pancreatitis.pdf
Itraconazole and paresthesias kwb_2005_1_itrac.pdf
Lamictal (lamotrigine) en alopecia kwb_2007_2_lamotr.pdf
Lamotrigine en ernstige huidreacties kwb_2000_2_lamot.pdf
Lanreotide and loss of scalp hair kwb_2004_1_lanre.pdf
Latanoprost and dizziness kwb_2007_1_latano.pdf
Latanoprost-oogdruppels en hoofdpijn kwb_2001_2_latan.pdf
Lithium intoxication associated with simultaneous use of trimethoprim kwb_2001_4_lithi.pdf
Loperamide en urineretentie kwb_2000_1_loper.pdf
Loratadine, desloratadine and convulsions kwb_2008_3_lorat.pdf
Losartan and psychiatric adverse drug reaction kwb_2005_4_losar.pdf
Losartan and taste disorders kwb_2005_2_losar.pdf
Low dose carbasalate calcium and tinnitus kwb_2006_3_carbas.pdf
Macrolide antibiotics and myasthenia kwb_2002_4_macro.pdf
Methylphenidate and hyperhidrosis kwb_2007_1_methylph.pdf
Miconazol en ontregeling van antistolling kwb_2001_2_micon.pdf
Minocycline en interstitiële pneumonie kwb_2000_2_minoc.pdf
Mirena and ectopic pregnancy kwb_2008_2_mirena.pdf
Mirtazapine en droge mond kwb_2001_4_mirta.pdf
Mirtazapine en myalgie kwb_2000_4_mirta.pdf
Mirtazapine SolTab and mouth paraesthesia / anaesthesia kwb_2003_2_mirta.pdf
Montelukast and depressive symptoms kwb_2006_4_montel.pdf
Nadroparin-induced calcinosis cutis in renal transplant recipients kwb_2002_1_nadro.pdf
Naphazoline and mydriasis kwb_2003_3_napha.pdf
Neonatale intracraniële bloeding geassocieerd met gebruik van paroxetine tijdens de zwangerschap kwb_2001_3_parox.pdf
Neuropsychiatric side effects associated with dextromethorphan kwb_2005_3_dextro.pdf
Nilutamide and chromotopsia kwb_2006_4_nilut.pdf
Olanzapine and amenorrhea kwb_2006_2_olanz.pdf
Olanzapine and hyponatraemia kwb_2006_1_olanz.pdf
Omeprazole and coumarine interactions kwb_2009_3_omepr.pdf
Omeprazole and erectyle dysfunction kwb_2006_4_omep.pdf
Omeprazole, esomeprazole and hypomagnesaemia kwb_2009_2_omepr.pdf
Oral iron salts and skin reactions kwb_2008_1_iron.pdf
Oseltamivir and coumarin potentiation kwb_2009_4_oselt.pdf
Overview of anakinra reports kwb_2003_3_anaki.pdf
Overview of cardiac adverse drug reactions reported in association with rosiglitazone kwb_2007_2_rosig.pdf
Overview of rosuvastatin reports kwb_2004_1_rosuv.pdf
Overview on pioglitazone kwb_2007_4_piog.pdf
Paroxetine and restless legs kwb_2008_3_parox.pdf
Pergolide and pathologic gambling kwb_2005_3_pergo.pdf
Pergolide en effect op libido kwb_2001_2_pergo.pdf
Pergolide en fibrosering kwb_2000_3_pergo.pdf
Phosphodiesterase 5 inhibitors and pulmonary embolism kwb_2009_2_phosp.pdf
Proton pump inhibitors and tongue discoloration kwb_2009_4_ppis.pdf
Proton-pump inhibitors and gynecomastia kwb_2005_3_proto.pdf
Quetiapine and extrapyramidal effects kwb_2006_1_queti.pdf
Quetiapine and micturation disorders kwb_2005_3_queti.pdf
Risperdal® en gestoorde glucose tolerantie kwb_2001_3_rispe.pdf
Risperidon and pipamperon in association with epistaxis kwb_2007_4_rispe.pdf
Risperidone and epistaxis kwb_2004_3_rispe.pdf
Rofecoxib en cardiale bijwerkingen kwb_2000_3_rofec.pdf
Salbutamol inhalation and dental caries kwb_2007_4_salbut.pdf
Selective serotonergic vasoconstrictors in suspected association with pain activation kwb_2002_1_tript.pdf
Serotonin Re-uptake Inhibitors (SSRI’s) and shocklike paraesthesia kwb_2002_2_ssris.pdf
Serotonin Re-uptake Inhibitors (SSRIs) and alopecia 2008-4 LQR - Serotonin Re-uptake Inhibitors and alopecia.pdf
Serotonin Re-uptake Inhibitors (SSRIs) and shock-like paraesthasias: an update 2008-4 LQR - Serotonin Reuptake Inhibitors and shock.pdf
Severe skin reactions in patients receiving cranial radiotherapy while using phenytoin. kwb_2003_3_pheny.pdf
Sevoflurane and ventricular tachycardia kwb_2006_1_sevof.pdf
Sibutramine and manic psychosis kwb_2002_1_sibut.pdf
Simvastatine en eczeem kwb_2000_1_simva.pdf
Skin reactions associated with the use of oral terbinafine kwb_2004_3_terbi.pdf
Sodium aurothiomalate and nitritoid reactions: concomitant use of an ACE-inhibitor as a contributing factor kwb_2004_3_taure.pdf
SSRI’s en galactorroe kwb_2000_2_ssris.pdf
SSRI’s en nauwe kamerhoek glaucoom kwb_2001_4_ssris.pdf
SSRIs and aggression kwb_2009_3_ssris.pdf
SSRIs and Hypoglycaemia kwb_2009_1_ssris.pdf
SSRIs and tinnitus kwb_2005_4_ssri.pdf
SSRIs and venlafaxine in association with bruxism kwb_2006_2_ssri.pdf
SSRIs and weight gain kwb_2003_2_ssris.pdf
Stocrin en leverfalen kwb_2001_3_efavi.pdf
Stomatitis associated with the use of terbinafine kwb_2001_4_terbi.pdf
Sulfasalazine-induced taste disorders kwb_2002_3_sulfa.pdf
Sumatriptan and zolmitriptan and emotional disinhibition kwb_2003_3_tript.pdf
Tamoxifen and hirsutism 2008-4 LQR Tamoxifen and hirsutism.pdf
Tamsulosin and epistaxis kwb_2009_4_tamsul.pdf
Tamsulosin and hyperglycemia in patients with type 2 diabetes 2009-1 LQR tamsulosin and hyperglycemia in patients with type 2 diabetes.pdf
Tamsulosin antagonists and anginal complaints kwb_2006_1_tamsu.pdf
Terbinafine and lupus erythematosus kwb_2003_4_terbi.pdf
Thyrax Duotab 0,025 mg® and allergic reaction kwb_2003_2_thyra.pdf
Topical imidazole derivates and drug interactions kwb_2009_3_imida.pdf
Topical tacrolimus and malignancies kwb_2006_3_tacro.pdf
Toxisch anticholinerg delier bij gelijktijdig gebruik van tolterodine en fluconazol kwb_2000_1_tolte.pdf
Tramadol and hallucinations kwb_2004_1_trama.pdf
Tramadol and hiccups kwb_2007_2_trama.pdf
tramadol and hot flushes kwb_2008_3_trama.pdf
Tramadol and myoclonus kwb_2002_3_trama.pdf
Valproic acid and curling hair kwb_2009_2_valpr.pdf
Valproic acid and gingivitis kwb_2008_3_valpr.pdf
Valproic acid and pubertas praecox kwb_2007_1_valpr.pdf
valproic acid is association with hyponatremia and SIADH kwb_2006_3_valpr.pdf
Venlafaxine and extrapyramidal effects kwb_2004_2_venla.pdf
Venlafaxine and hypertension kwb_2003_4_venla.pdf
Venlafaxine and severe respiratory disorders kwb_2003_2_venla.pdf
Venlafaxine and sexual disinhibition kwb_2007_1_venla.pdf
Vitamin B12 induced acneiform dermatitis kwb_2005_4_vitab.pdf
Zyban® en ballisme kwb_2001_4_bupro.pdf

 

 

Problemen met het lezen van PDF bestanden?
Download de Adobe Reader Download the PDF reader